Antioxidant Therapy and Atherosclerosis Animal and Human Studies
作者： Emma Meagher , Daniel J Rader
DOI: 10.1016/S1050-1738(01)00105-0
关键词:
摘要: … Oxidation of LDL cholesterol appears to play a central role in the pathogenesis of atherosclerosis. Animal models of atherosclerosis have elucidated this process and have …
elsevier.com
sci-hub.se 参考文章(28)
Salim Yusuf, G Dagenais, J Pogue, J Bosch, P Sleight, None, Vitamin E supplementation and cardiovascular events in high-risk patients. The New England Journal of Medicine. ,vol. 342, pp. 154- 160 ,(2000) , 10.1056/NEJM200001203420302
Paul K. Witting, Knut Pettersson, Anne-Margret Östlund-Lindqvist, Christer Westerlund, Annika Westin Eriksson, Roland Stocker, Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice The FASEB Journal. ,vol. 13, pp. 667- 675 ,(1999) , 10.1096/FASEBJ.13.6.667
O.P. Heinonen, D. Albanes, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers The New England Journal of Medicine. ,vol. 330, pp. 1029- 1035 ,(1994)
Paul K Witting, Knut Pettersson, Jacinta Letters, Roland Stocker, Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice11Dedicated to Lars Ernster for his pioneering contributions to research into coenzyme Q and his genuine passion and enthusiasm we were privileged to experience. Free Radical Biology and Medicine. ,vol. 29, pp. 295- 305 ,(2000) , 10.1016/S0891-5849(00)00311-7
Eric B. Rimm, Meir J. Stampfer, ANTIOXIDANTS FOR VASCULAR DISEASE Medical Clinics of North America. ,vol. 84, pp. 239- 249 ,(2000) , 10.1016/S0025-7125(05)70216-9
John A. Lawson, Joshua Rokach, Garret A. FitzGerald, Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo Journal of Biological Chemistry. ,vol. 274, pp. 24441- 24444 ,(1999) , 10.1074/JBC.274.35.24441
Masaaki Miyata, Jonathan D. Smith, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nature Genetics. ,vol. 14, pp. 55- 61 ,(1996) , 10.1038/NG0996-55
T. Kita, Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, H. Yoshida, C. Kawai, Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 5928- 5931 ,(1987) , 10.1073/PNAS.84.16.5928
Domenico Praticò, Rajendra K. Tangirala, Daniel J. Rader, Joshua Rokach, Garret A. FitzGerald, Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nature Medicine. ,vol. 4, pp. 1189- 1192 ,(1998) , 10.1038/2685
T. E. Carew, D. C. Schwenke, D. Steinberg, Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7725- 7729 ,(1987) , 10.1073/PNAS.84.21.7725